Ketamine inhibits lipopolysaccharide-induced astrocytes activation by suppressing TLR4/NF-κB pathway

Cellular Physiology and Biochemistry

Volumn 30, Issue 3, 2012, Pages 609-617

  Zhang, Yong ^b   Wu, Yuqing ^a   Li, Wei ^a   Zhou, Ce ^a   Lu, Fuzhao ^a   Gao, Tianhui ^a   Liu, Yingchun ^a   Cao, Junli ^a   Zhang, Yongmei ^a   Zhou, Chenghua ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Sixth People's Hospital of Xuzhou City   (China)

Author keywords

Astrocyte; Cytokine; GFAP; Inflammation; Ketamine; NF B; TLR4

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KETAMINE; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE; ATTENUATION; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE TEST; INFLAMMATION; INHIBITION KINETICS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84864089849     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341442     Document Type: Article

References (43)

1. Aschner M: Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 1998;19:269-281.
2. Aschner M, Sonnewald U, Tan KH: Astrocyte modulation of neurotoxic injury. Brain Pathol 2002;12:475-481.
3. Dong Y, Benveniste EN: Immune function of astrocytes. Glia 2001;36:180-190.
4. Munoz-Fernandez MA, Fresno M: The role of tumour necrosis factor, interleukin-6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 1998;56:307-340.
5. Barcia C, Ros CM, Annese V, Gómez A, Ros-Bernal F, Aguado-Yera D, Martínez-Pagán ME, de Pablos V, Fernandez-Villalba E, Herrero MT: IFN-y signaling, with the synergistic contribution of TNF-a, mediates cell specific microglial and astroglial activation in experimental models of Parkinsons disease. Cell Death Dis 2011;2:e142.
6. Serrano-Pozo A, Mielke ML, Gómez-Isla T, Betensky RA, Growdon JH, Frosch MP, Hyman BT: Reactive glia not only associates with plaques but also parallels tangles in Alzheimers disease. Am J Pathol 2011;179:1373-1384.
7. Takenaka I, Ogata M, Koga K, Matsumoto T, Shigematsu A: Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 1994;80:402-408.
8. Shimaoka M, Iida T, Ohara A, Taenaka N, Mashimo T, Honda T, Yoshiya I: Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br J Anaesth 1996;77:238-242.
9. Kawasaki T, Ogata M, Kawasaki C, Ogata J, Inoue Y, Shigematsu A: Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 1999;89:665-669.
10. Shibakawa YS, Sasaki Y, Goshima Y, Echigo N, Kamiya Y, Kurahashi K, Yamada Y, Andoh T: Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br J Anaesth 2005;95:803-810.
11. Mei X, Wang W, Wang W, Li Y, Zhang H, Wu S, Li Y, Xu L: Inhibiting astrocytic activation: a novel analgesic mechanism of ketamine at the spinal level? J Neurochem 2009;109:1691-1700.
12. Mei XP, Zhang H, Wang W, Wei YY, Zhai MZ, Wang W, Xu LX, Li YQ: Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain. J Neuroinflammation 2011;8:6.
13. ONeill L: The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem Soc Trans 2000;28:557-563.
14. Bowman CC, Rasley A, Tranguch SL, Marriott I: Cultured astrocytes express Toll-like receptors for bacterial products. Glia 2003;43:281-291.
15. Akira S, Takeda K: Toll-like receptor signalling. Nature Rev 2004;4:499-511.
16. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-179.
17. Sasaki Y, Takimoto M, Oda K, Früh T, Takai M, Okada T, Hori S: Endothelin evokes efflux of glutamate in cultures of rat astrocytes. J Neurochem 1997;68:2194-2200.
18. Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, Domino SE: Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982;61:87-92.
19. Zhao G, Flavin M: Differential sensitivity of rat hippocampal and cortical astrocytes to oxygen-glucose deprivation injury. Neurosci Lett 2000;285:177-180.
20. Smith SJ: Do astrocytes process neural information? Prog Brain Res 1992;94:119-136.
21. Desagher S, Glowinski J, Premont J: Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 1996;16:2553-2562.
22. Dugan L, Bruno V, Amagasu S, Giffard R: Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci 1995;15:4545-4555.
23. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell 2010;140:918-934.
24. Sofroniew MV, Vinters HV: Astrocytes: biology and pathology. Acta Neuropathol 2010;119:7-35.
25. Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B: Glial TLR4 receptor as new target to treat neuropathic pain efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 2008;56:1312-1319.
26. Saito O, Svensson CI, Buczynski MW, Wegner K, Hua XY, Codeluppi S, Schaloske RH, Deems RA, Dennis EA, Yaksh TL: Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF Br J Pharmacol 2010;160:1754-1764.
27. Wu GJ, Chen TL, Ueng YF, Chen RM: Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 2008;228:105-113.
28. Yu M, Shao D, Feng X, Duan M, Xu J: Effects of ketamine on pulmonary TLR4 expression and NF-kappa-B activation during endotoxemia in rats. Methods Find Exp Clin Pharmacol 2007;29:395-399.
29. Dunzendorfer S, Lee HK, Soldau K, Tobias PS: Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J 2004;18:1117-1119.
30. Ohnishi T, Muroi M, Tanamoto K: The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2. FEMS Immunol Med Microbiol 2007;51:84-91.
31. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll like receptor 4 TLR4 deficient mice are hyporesponsive to lipopolysaccharide evidence for TLR4 as the LPS gene product. J Immunol 1999;162:3749-3752.
32. Da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ: Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001;276:21129-21135.
33. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T: Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 2002;277:47834-47843.
34. Feng Y, Longmore GD: The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex. Mol Cell Biol 2005;25:4010-4022.
35. Wright JG, Christman JW: The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med 2003;2:211-219.
36. Baeuerle PA, Baltimore D: I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988;242:540-546.
37. Grilli M, Chiu JJ, Leonardo MJ: NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993;143:1-62.
38. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA: Nuclear factor-kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993;187:233-256.
39. Jiang Q, Akashi S, Miyake K, Petty HR: Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000;165:3541-3544.
40. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH: Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 2000;20:7037-7042.
41. Kuang X, Huang Y, Gu HF, Zu XY, Zou WY, Song ZB, Guo QL: Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol 2012;676:51-56.
42. Lin ST, Wang Y, Xue Y, Feng DC, Xu Y, Xu LY: Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway. Mol Cell Biochem 2008;315:41-49.
43. Lee SY, Son DJ, Lee YK, Lee JW, Lee HJ, Yun YW, Ha TY, Hong JT: Inhibitory effect of sesaminol glucosides on lipopolysaccharide-induced NF-kappaB activation and target gene expression in cultured rat astrocytes. Neurosci Res 2006;56:204-212.